Back to today’s briefing

Story perspectives

Revolutionary INDUCE-seq® Tech Transforms Gene Editing Safety Assessments

2/7/2025

43 3

Summary

Story summary

Broken String Biosciences has unveiled an early access program for its groundbreaking INDUCE-seq® technology, revolutionizing the detection and quantification of DNA breaks from gene editing. This innovative tool promises to standardize safety assessments in gene-edited therapies, ensuring regulatory compliance while offering precision and adaptability across diverse therapeutic fields.

1 of 1

Story summary

Broken String Biosciences has unveiled an early access program for its groundbreaking INDUCE-seq® technology, revolutionizing the detection and quantification of DNA breaks from gene editing. This innovative tool promises to standardize safety assessments in gene-edited therapies, ensuring regulatory compliance while offering precision and adaptability across diverse therapeutic fields.